J. Park

发表

Mixture Joint Models for Event Time and Longitudinal Data With Multiple Features

Yangxin Huang, G. Dagne, J. Park, 2016 .

Pharmacodynamics of Antiretroviral Agents in HIV-1 Infected Patients: Using Viral Dynamic Models that Incorporate Drug Susceptibility and Adherence

Alan S. Perelson, Hulin Wu, Song Yu, 2006, Journal of Pharmacokinetics and Pharmacodynamics.

Safety , Tolerability , and Pharmacokinetic Interactions of the Antituberculous Agent TMC 207 ( Bedaquiline ) With Efavirenz in Healthy Volunteers : AIDS Clinical Trials Group Study A 5267

K. Dooley, J. Park, C. Flexner, 2012 .

Effect of Low-Dose Ritonavir on the Pharmacokinetics of the CXCR4 Antagonist AMD070 in Healthy Volunteers

J. Park, C. Flexner, C. Hendrix, 2008, Antimicrobial Agents and Chemotherapy.

Contraceptive Efficacy of Oral and Transdermal Hormones When Co-Administered With Protease Inhibitors in HIV-1-Infected Women: Pharmacokinetic Results of ACTG Trial A5188

J. Park, F. Aweeka, S. Cohn, 2010, Journal of acquired immune deficiency syndromes.

Pharmacokinetics of Nelfinavir and Efavirenz in Antiretroviral-Naïve, Human Immunodeficiency Virus-Infected Subjects when Administered Alone or in Combination with Nucleoside Analog Reverse Transcriptase Inhibitors

M. Hirsch, T. Merigan, R. Shafer, 2005, Antimicrobial Agents and Chemotherapy.

Depot Medroxyprogesterone Acetate in Combination with a Twice-Daily Lopinavir-Ritonavir-Based Regimen in HIV-Infected Women Showed Effective Contraception and a Lack of Clinically Significant Interactions, with Good Safety and Tolerability: Results of the ACTG 5283 Study

J. Park, F. Aweeka, S. Cohn, 2015, Antimicrobial Agents and Chemotherapy.

Sex Differences in Lopinavir and Ritonavir Pharmacokinetics Among HIV‐Infected Women and Men

J. Park, C. Fletcher, J. Currier, 2011, Journal of clinical pharmacology.

Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women

J. Park, R. Bosch, F. Aweeka, 2016, Journal of acquired immune deficiency syndromes.

Predictive Value of Pharmacokinetics-Adjusted Phenotypic Susceptibility on Response to Ritonavir-Enhanced Protease Inhibitors (PIs) in Human Immunodeficiency Virus-Infected Subjects Failing Prior PI Therapy

R. Haubrich, D. Richman, J. Park, 2009, Antimicrobial Agents and Chemotherapy.

Phase I Safety, Pharmacokinetics, and Pharmacogenetics Study of the Antituberculosis Drug PA-824 with Concomitant Lopinavir-Ritonavir, Efavirenz, or Rifampin

K. Dooley, J. Park, D. Haas, 2014, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of Nelﬁnavir and Efavirenz in Antiretroviral-Naı¨ve, Human Immunodeﬁciency Virus-Infected Subjects when Administered Alone or in Combination with Nucleoside Analog Reverse Transcriptase Inhibitors

M. Hirsch, T. Merigan, R. Shafer, 2005 .

Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093.

J. Park, S. Cohn, Song Yu, 2008, Contraception.

Model-Based Estimates of the Effects of Efavirenz on Bedaquiline Pharmacokinetics and Suggested Dose Adjustments for Patients Coinfected with HIV and Tuberculosis

Mats O. Karlsson, Elin M. Svensson, Jeong-Gun Park, 2013, Antimicrobial Agents and Chemotherapy.

Multiple-Dose Escalation Study of the Safety, Pharmacokinetics, and Biologic Activity of Oral AMD070, a Selective CXCR4 Receptor Inhibitor, in Human Subjects

J. Park, C. Flexner, C. Hendrix, 2007, Antimicrobial Agents and Chemotherapy.

Segmental modeling of changing immunologic response for CD4 data with skewness, missingness and dropout

Yangxin Huang, Getachew A. Dagne, Jeong-Gun Park, 2013 .

Effect of Low-Dose Ritonavir on the Pharmacokinetics of the CXCR 4 Antagonist AMD 070 in Healthy Volunteers †

J. Park, C. Flexner, C. Hendrix, 2008 .

Effect of Low-Dose Ritonavir on the Pharmacokinetics of the CXCR4 Antagonist AMD070 in Healthy Volunteers (cid:1) †

J. Park, C. Flexner, C. Hendrix, 2008 .

Safety, Tolerability, and Pharmacokinetic Interactions of the Antituberculous Agent TMC207 (Bedaquiline) With Efavirenz in Healthy Volunteers: AIDS Clinical Trials Group Study A5267

K. Dooley, J. Park, C. Flexner, 2012, Journal of acquired immune deficiency syndromes.

Novel Dosing Strategies Increase Exposures of the Potent Antituberculosis Drug Rifapentine but Are Poorly Tolerated in Healthy Volunteers

K. Dooley, S. Dorman, J. Park, 2015, Antimicrobial Agents and Chemotherapy.

Depo‐medroxyprogesterone in Women on Antiretroviral Therapy: Effective Contraception and Lack of Clinically Significant Interactions

J. Park, S. Cohn, Song Yu, 2007, Clinical pharmacology and therapeutics.

Backfitting and local likelihood methods for nonparametric mixed-effects models with longitudinal data

J. Park, Hulin Wu, 2006 .

Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women

J. Park, S. Cohn, A. Weinberg, 2016, Journal of acquired immune deficiency syndromes.